Re-fixating Dislocated Scleral Fixing Intra-ocular Lens

Intraocular Lens Complication Clinical Trial

Official title:

A Novel Technique of Re-fixating Dislocated Scleral Fixing Intra-ocular Lens

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05278949
• Other study ID #: IMER 14
• Status: Completed
• Phase: N/A
• Start date: January 1, 2022
• Est. completion date: March 21, 2023

Study information

• Verified date: March 2023
• Source: Ibinsina Modern Eye and Retina Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To minimize multiple manipulations and to decrease the economical burden; here, we describe how to utilize the patient's own dislocated intraocular lens to re-fixate with the sclera.

Description:

When a scleral fixated intraocular lens (IOL) is displaced; routinely it is extracted and exchanged with another IOL and re-fixated to the sclera or another modality can be used. Both can carry many complications due to multiple manipulations. Nevertheless, suture and/or haptic end exposure is another expected future complication, which can range from foreign body sensation to endophthalmitis.

Here, the investigators utilized the same participant's IOL with minimum manipulations and the haptic ends buried inside scleral pockets to prevent future exposure and complications. The pocket entry is sutured with 8/0 vicryl, which is absorbable, to overcome complications.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5
• Est. completion date: March 21, 2023
• Est. primary completion date: March 21, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Dislocated primary scleral fixed IOL

Exclusion Criteria:

• Iris claw IOL

• Anterior chamber IOL

Related Conditions & MeSH terms

• Intraocular Lens Complication

Intervention

Other:
• The surgical intervention
The participant's primary IOL is re-fixed without utilizing any new material.

Locations

Country	Name	City	State
Iraq	Ibinsina Modern eye and retina center	Erbil

Sponsors (1)

Lead Sponsor	Collaborator
Omer Othman Abdullah

Country where clinical trial is conducted

Iraq, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The slit-lamp examination.	To assess the intra-ocular pressure mmHg, the re-fixated intraocular lens position ( central, tilted or displaced),and leakage from the incisions, and the hemorrhage ( whether in the anterior segment or in the posterior segment).	The fourth week post-operatively.
Secondary	The visual acuity.	To assess both the uncorrected and the best corrected visual acuity ( with glasses).	The fourth week post-operatively.